BMW Keeps 2026 Outlook Despite 25% Profit Drop Amid Tariff Pressure 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Regis Resources and Vault Minerals to Merge in $10.7B Gold Deal 
Palantir Reports Record Growth, Raises 2026 Revenue Outlook Above Expectations 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
GameStop Proposes $56 Billion eBay Acquisition in Bold Strategic Move 
Continental AG Shares Jump After Q1 Profit Beats Expectations 
Philips Reaffirms 2026 Outlook After Strong Q1 Sales and Margin Beat 
Anthropic Secures $1.5B AI Venture Backed by Wall Street Giants, Shaking Software Sector 
Strategy Reports Q1 Loss as Bitcoin Holdings Trigger $14.46 Billion Unrealized Hit 
Middle East Conflict Impacts Australia and New Zealand Businesses 
AMD Q1 Earnings Surge on AI Demand, Stock Jumps After Strong Guidance 
Pinterest Stock Surges After Strong Q1 2026 Earnings Beat Expectations 
Rivian Hints at New R2 Variants as Production Ramps Up Ahead of 2027 Launch 
Samsung Surpasses $1 Trillion Market Cap Amid AI Chip Boom and Apple Partnership Talks 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
BETHLEHEM, Pa., May 03, 2018 -- B. Braun Medical Inc., an industry pioneer in offering products not made with DEHP and PVC, will showcase its portfolio of solution containers at the CleanMed 2018 Conference & Exposition on May 7-9 at the Sheraton San Diego Hotel and Marina in booth #203.
Di-ethylhexyl Phthalate (DEHP) and Polyvinyl Chloride (PVC) are potentially toxic to patients and the environment – and they’re commonly used in IV bags, tubing, and packaging.
“B. Braun has been at the forefront of recognizing the patient and environmental risk posed by exposure to products containing DEHP and PVC. We were one of the first IV fluid manufacturers to remove these toxic substances from many of our products and proudly remain the only supplier that offers a full-line of IV solution containers that are not made with DEHP and PVC,” said Tom Sutton, Vice President of Marketing, Medical Device and Pharmaceutical Systems.
Over the past seven years, B. Braun has invested more than $750 million in developing increased capacity, and innovative ways to offer environmentally friendly IV solutions. This includes new product lines not made with DEHP, PVC, or natural rubber latex. B. Braun actively supports policies calling for the industry-wide reduction of these chemicals and natural rubber latex in medical devices.
For more information on these products, call B. Braun Clinical and Technical Support at 800-854-6851. For more information on DEHP and PVC in healthcare, visit www.BBraunCares.com.
About B. Braun
B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include ostomy and wound care, dialysis, nutrition, pharmacy admixture and compounding. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
Globally, the B. Braun Group of Companies employs more than 61,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com.
Contact: Jason Ford
B. Braun Medical Inc.
610.997.4722
[email protected]
